http://www.bemymd.com Your online MD who really cares about YOU. Tue, 06 Jan 2009 07:55:09 +0000 http://backend.userland.com/rss092 en Caralluma fimbriata is a succulent plant, in the cactus family, that has been used as a natural appetite suppressant in India for centuries. It's a new arrival in the family of cactii and succulent plants that are becoming increasingly popular for th... http://www.bemymd.com/2009/01/06/what-you-need-to-know-about-caralluma-fimbriata/ The U.S. Food and Drug Administration announced a Class I recall of lot no. UD30654 of Healon D, an ophthalmic viscosurgical device (OVD) manufactured by Advanced Medical Optics Inc. (AMO) of Santa Ana, Calif. http://www.bemymd.com/2009/01/02/fda-announces-class-i-recall-of-ophthalmic-surgical-device/ The U.S. Food and Drug Administration announced today that the District Court for the District of New Mexico has enjoined Do-Rene and Clover Knolls Dairies and their owners, Douglas B. Handley and Irene Handley, from adulterating new animal drugs and introducing adulterated food into commerce. Both companies are based in ... http://www.bemymd.com/2009/01/02/fda-prevents-two-dairies-from-adulterating-animal-drugs-and-food/ The U.S. Food and Drug Administration today approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood plasma and tissue. http://www.bemymd.com/2008/12/30/fda-approves-first-nucleic-acid-test-to-screen-for-additional-types-of-hiv-in-donated-blood-and-tissue/ The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer. It belongs to a class of agents called gonadotropin releasing hormone (GnRH) receptor inhibitors. These agents slow the ... http://www.bemymd.com/2008/12/29/fda-approves-drug-for-patients-with-advanced-prostate-cancer/ The U.S. Food and Drug Administration today approved Vasovist Injection (gadofosveset trisodium), the first contrast imaging agent for use in patients undergoing magnetic resonance angiography, or MRA, a minimally invasive test for examining blood vessels. http://www.bemymd.com/2008/12/24/fda-approves-first-imaging-agent-to-enhance-scans-of-blood-flow/ The U.S. Food and Drug Administration is alerting consumers nationwide not to purchase or consume more than 25 different products marketed for weight loss because they contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk. http://www.bemymd.com/2008/12/22/fda-warns-consumers-about-tainted-weight-loss-pills/ The U.S. Food and Drug Administration announced today that the District Court for the Western District of Missouri entered a Consent Decree on Dec. 15, 2008, prohibiting Milbank Mills, an animal feed mill in Chillicothe, Mo., from manufacturing, processing, or distributing medicated animal feed. Milbank Mills and its officers Edward ... http://www.bemymd.com/2008/12/22/fda-obtains-injunction-to-stop-production-of-illegally-medicated-animal-feed/ The U.S. Food and Drug Administration recommended today that manufacturers developing new drugs and biologics for type 2 diabetes provide evidence that the therapy will not increase the risk of such cardiovascular events as a heart attack. The recommendation is part of a new guidance for industry that applies to ... http://www.bemymd.com/2008/12/17/fda-announces-new-recommendations-on-evaluating-cardiovascular-risk-in-drugs-intended-to-treat-type-2-diabetes/ The U.S. Food and Drug Administration today announced it will require the manufacturers of antiepileptic drugs to add to these products' prescribing information, or labeling, a warning that their use increases risk of suicidal thoughts and behaviors (suicidality). http://www.bemymd.com/2008/12/16/fda-requires-warnings-about-risk-of-suicidal-thoughts-and-behavior-for-antiepileptic-medications/